Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
All Genders
NCT07370727

Velocity-Based Resistance Training in Kidney Transplant Recipients

Led by Fundación Universitaria del Area Andina · Updated on 2026-01-27

12

Participants Needed

1

Research Sites

113 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized controlled trial aims to evaluate the effects of velocity-based resistance training on renal function and metabolic health in kidney transplant recipients. Participants will be randomized into two groups performing resistance training at different execution velocities (maximal intended vs. submaximal controlled). The intervention will last 12 weeks and include multi-joint exercises (squat, bench press, military press). Primary outcomes include renal function (serum creatinine, eGFR, blood urea nitrogen, uric acid) and metabolic markers (HDL, triglycerides, glucose, waist circumference, blood pressure). Secondary outcomes include muscle strength, force-velocity profile, anthropometry, physical activity, fitness perception, and adherence to immunosuppressive medication.

CONDITIONS

Official Title

Velocity-Based Resistance Training in Kidney Transplant Recipients

Who Can Participate

Age: 18Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women aged 18 to 50 years
  • Kidney transplant performed 12 months or more before enrollment
  • Stable graft function in the previous 6 months (serum creatinine < 1.5 mg/dL, no rejection episodes)
  • Written medical clearance from a nephrologist to perform moderate-to-vigorous physical activity
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Active autoimmune disorders
  • Recent coronary disease (within 6 months)
  • Severe musculoskeletal limitations preventing resistance training
  • Diagnosis of diabetes mellitus (pre- or post-transplant)
  • Current active infection
  • Use of immunosuppressive drugs contraindicated for exercise (e.g., mTOR inhibitors at baseline)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Colombia

Bogotá, Bogota D.C., Colombia, 0000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here